Sean Gaskell
Technik-/Wissenschafts-/F&E-Leiter bei Alvotech hf
Profil
Sean Gaskell is currently the Chief Technical Officer at Alvotech hf.
Prior to his current position, he held the role of Vice President-Manufacturing Operations at Novartis Gene Therapies, Inc. from 2018 to 2020.
He also served as the Site Head at Novartis AG.
Dr. Gaskell has a background in undergraduate and doctorate studies from Loughborough University.
Aktive Positionen von Sean Gaskell
| Unternehmen | Position | Beginn |
|---|---|---|
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2020 |
Ehemalige bekannte Positionen von Sean Gaskell
| Unternehmen | Position | Ende |
|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | 01.01.2020 |
| NOVARTIS AG | Corporate Officer/Principal | - |
| ALVOTECH | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Sean Gaskell
| Loughborough University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALVOTECH | Health Technology |
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |
